Apeiron Capital »

Summit Therapeutics shares owned by Apeiron Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Apeiron Capital from 13F filings

Historical chart of Apeiron Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Apeiron Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Apeiron Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $27M 1.3M 20.66
2025-06-30 $23M 1.2M 19.29